CA2518508A1 - Differentiation of human embryonic stem cells to cardiomyocytes - Google Patents

Differentiation of human embryonic stem cells to cardiomyocytes Download PDF

Info

Publication number
CA2518508A1
CA2518508A1 CA002518508A CA2518508A CA2518508A1 CA 2518508 A1 CA2518508 A1 CA 2518508A1 CA 002518508 A CA002518508 A CA 002518508A CA 2518508 A CA2518508 A CA 2518508A CA 2518508 A1 CA2518508 A1 CA 2518508A1
Authority
CA
Canada
Prior art keywords
cell
cardiomyocyte
cells
differentiated
hes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002518508A
Other languages
English (en)
French (fr)
Inventor
Christine Lindsay Mummery
Petrus Adrianus Frederik Maria Doevendans
Leon Gerardus Joseph Tertoolen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NETHERLANDS INSTITUUT VOOR ONTWIKKELINGSBIOLOGIE
ES Cell International Pte Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2518508A1 publication Critical patent/CA2518508A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657Cardiomyocytes; Heart cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/02Coculture with; Conditioned medium produced by embryonic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002518508A 2003-03-11 2004-03-11 Differentiation of human embryonic stem cells to cardiomyocytes Abandoned CA2518508A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2003901099A AU2003901099A0 (en) 2003-03-11 2003-03-11 Methods of inducing differentiation of stem cells
AU2003901099 2003-03-11
PCT/AU2004/000302 WO2004081205A1 (en) 2003-03-11 2004-03-11 Differentiation of human embryonic stem cells to cardiomyocytes

Publications (1)

Publication Number Publication Date
CA2518508A1 true CA2518508A1 (en) 2004-09-23

Family

ID=31500143

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002518508A Abandoned CA2518508A1 (en) 2003-03-11 2004-03-11 Differentiation of human embryonic stem cells to cardiomyocytes

Country Status (7)

Country Link
US (1) US20070161107A1 (enExample)
EP (1) EP1608740A4 (enExample)
JP (1) JP2006523091A (enExample)
AU (1) AU2003901099A0 (enExample)
CA (1) CA2518508A1 (enExample)
GB (1) GB2415437A (enExample)
WO (1) WO2004081205A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023035479A1 (zh) * 2021-09-07 2023-03-16 北京中医药大学 中药复合物、中药有效组分组合物、化合物及其应用

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL159580A0 (en) 2001-07-12 2004-06-01 Geron Corp Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
US7732199B2 (en) 2001-07-12 2010-06-08 Geron Corporation Process for making transplantable cardiomyocytes from human embryonic stem cells
US7452718B2 (en) 2004-03-26 2008-11-18 Geron Corporation Direct differentiation method for making cardiomyocytes from human embryonic stem cells
CA2569242A1 (en) * 2004-06-01 2005-12-15 Es Cell International Pte Ltd Improved cardiomyocyte differentiation
KR20130099253A (ko) 2005-06-22 2013-09-05 제론 코포레이션 영장류 다능성 줄기 세포의 심근세포 계통 세포로의 분화
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
KR101420740B1 (ko) 2005-12-13 2014-07-17 교또 다이가꾸 핵초기화 인자
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
US8129187B2 (en) 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
KR20090086260A (ko) * 2006-12-07 2009-08-11 테바 파마슈티컬 인더스트리즈 리미티드 미손상 골수 또는 미손상 제대 조직으로부터 조직 전구체 세포 및 성숙 조직 세포를 형성 및 증식시키는 방법
US20080300642A1 (en) * 2007-05-30 2008-12-04 Japan As Represented By President Of National Cardiovascular Center Regeneration treatment apparatus, operating method thereof, and regeneration treatment method
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US9213999B2 (en) 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
WO2009036220A2 (en) * 2007-09-12 2009-03-19 The Regents Of The University Of California Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytes
KR101532442B1 (ko) 2007-12-10 2015-06-29 고쿠리츠 다이가쿠 호진 교토 다이가쿠 효율적인 핵 초기화 방법
US9683232B2 (en) 2007-12-10 2017-06-20 Kyoto University Efficient method for nuclear reprogramming
SG188098A1 (en) 2008-01-30 2013-03-28 Geron Corp Synthetic surfaces for culturing stem cell derived cardiomyocytes
ES2690554T3 (es) 2008-03-17 2018-11-21 The Scripps Research Institute Enfoques químicos y genéticos combinados para la generación de células madre pluripotentes inducidas
ES2722198T3 (es) 2008-05-02 2019-08-08 Univ Kyoto Método de reprogramación nuclear
KR101746864B1 (ko) * 2008-10-24 2017-06-14 주식회사 쿠라레 세포 보존 방법 및 세포 수송 방법
ES2645869T3 (es) 2008-12-17 2017-12-11 The Scripps Research Institute Generación y mantenimiento de células madre
EP2434007A4 (en) 2009-05-22 2013-07-31 Univ Tokyo Womens Medical METHOD FOR CREATING THE DIFFERENTIATION OF EMBRYONIC STEM CELLS OR ARTIFICIAL PLURIPOTENTER STEM CELLS
ES2638464T3 (es) 2009-10-16 2017-10-20 The Scripps Research Institute Inducción de células pluripotentes
AU2011235212B2 (en) 2010-03-31 2014-07-31 The Scripps Research Institute Reprogramming cells
AU2010355614B2 (en) * 2010-06-13 2015-07-02 Institute Of Biophysics, Chinese Academy Of Sciences Methods and compositions for preparing cardiomyocytes from stem cells and uses thereof
EP3399026B1 (en) 2010-06-14 2024-06-26 The Scripps Research Institute Reprogramming of cells to a new fate
CN106893692B (zh) 2010-12-22 2021-11-26 菲特治疗公司 用于单细胞分选与增强ipsc重新编程的细胞培养平台
EP2750509B1 (en) 2011-08-30 2016-12-28 The J. David Gladstone Institutes Methods for generating cardiomyocytes
EP2891712A4 (en) 2012-07-23 2016-04-06 Inst Biophysics Cn Acad Sci METHOD FOR INDUCTING PLURIPOTENTAL STEM CELLS FOR DIFFERENTIATING VENTRICULAR IN MYOCYTES IN VITRO
EP2948542A4 (en) 2013-01-23 2016-07-13 Ronald Li MANIPULATED PHYSICAL ORIENTATION OF CARDIOMYOCYTES FROM STEM CELLS
JPWO2015025958A1 (ja) * 2013-08-23 2017-03-02 国立大学法人大阪大学 ペースメーカー組織片の製造方法
US10087436B2 (en) 2014-02-06 2018-10-02 The Regents Of The University Of California Electrophysiologically mature cardiomyocytes and methods for making same
SG10201807292YA (en) 2014-03-04 2018-09-27 Fate Therapeutics Inc Improved reprogramming methods and cell culture platforms
AU2016338680B2 (en) 2015-10-16 2022-11-17 Fate Therapeutics, Inc. Platform for the induction and maintenance of ground state pluripotency
AU2024213547A1 (en) 2023-01-31 2025-08-14 Fujifilm Corporation Drug evaluation method, reagent and kit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002317039B2 (en) * 2001-07-24 2007-10-04 Es Cell International Pte Ltd Methods of inducing differentiation of stem cells
KR20050026008A (ko) * 2002-07-26 2005-03-14 위스콘신 얼럼나이 리서어치 화운데이션 인간 배아 줄기 세포로부터의 기능성 심근 세포
WO2005054448A1 (en) * 2003-12-04 2005-06-16 Guhathakurta Dr Soma A novel process and method for deriving cardiomyocyte precursors from bone-marrow stem cells

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023035479A1 (zh) * 2021-09-07 2023-03-16 北京中医药大学 中药复合物、中药有效组分组合物、化合物及其应用
US12194063B2 (en) 2021-09-07 2025-01-14 Beijing University Of Chinese Medicine Traditional Chinese medicine mixture and traditional Chinese medicine effective ingredient compound with function of promoting directional differentiation of stem cells into cardiomyocytes, and applications thereof

Also Published As

Publication number Publication date
GB2415437A (en) 2005-12-28
US20070161107A1 (en) 2007-07-12
EP1608740A1 (en) 2005-12-28
EP1608740A4 (en) 2007-05-09
JP2006523091A (ja) 2006-10-12
GB0520673D0 (en) 2005-11-16
WO2004081205A1 (en) 2004-09-23
AU2003901099A0 (en) 2003-03-27
WO2004081205A8 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
CA2518508A1 (en) Differentiation of human embryonic stem cells to cardiomyocytes
US9994822B2 (en) Cardiomyocyte differentiation
AU2002317039B2 (en) Methods of inducing differentiation of stem cells
Zandstra et al. Scalable production of embryonic stem cell-derived cardiomyocytes
AU2002317039A1 (en) Methods of inducing differentiation of stem cells
Moon et al. The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction
JP5750130B2 (ja) ヒト胚盤胞由来幹細胞に由来する多能性非収縮心臓前駆細胞の新規の集団
CN101341245A (zh) 获取祖细胞系的方法
JPWO2007088874A1 (ja) 幹細胞及び胎児由来の心筋細胞及び予定心筋細胞の精製方法
US20080254003A1 (en) Differentiation of Human Embryonic Stem Cells and Cardiomyocytes and Cardiomyocyte Progenitors Derived Therefrom
Wobus et al. Embryonic stem cell-derived cardiac differentiation: modulation of differentiation and “loss-of-function” analysis in vitro
Segev et al. Molecular analysis of cardiomyocytes derived from human embryonic stem cells
Moore et al. A P19Cl6 GFP reporter line to quantify cardiomyocyte differentiation of stem cells.
AU2004219990A1 (en) Differentiation of human embryonic stem cells to cardiomyocytes
AU2005318931A1 (en) Differentiation of human embryonic stem cells and cardiomyocytes and cardiomyocyte progenitors derived therefrom
JP2008141973A (ja) 心筋細胞の培養増殖法
Shafa et al. Stirred Suspension Bioreactor Suppresses ESC Differentiation
Mummery et al. Part A: Directed Differentiation of Human Embryonic Stem Cells into Cardiomyocytes
MUMMERY et al. 13, Part A

Legal Events

Date Code Title Description
FZDE Discontinued